Thromb Haemost 2006; 95(03): 551-556
DOI: 10.1160/TH05-09-0617
New Technologies, Diagnostic Tools and Drugs
Schattauer GmbH

Mutations in coagulation factor XIII A gene in eight unrelated Indians

Five novel mutations identified by a novel PCR-CSGE approach
Giridhara R. Jayandharan
1   Departments of Hematology and Clinical Pathology*, Christian Medical College, Vellore, India
,
Auro Viswabandya
1   Departments of Hematology and Clinical Pathology*, Christian Medical College, Vellore, India
,
Shoma Baidya
1   Departments of Hematology and Clinical Pathology*, Christian Medical College, Vellore, India
,
Sukesh C. Nair
1   Departments of Hematology and Clinical Pathology*, Christian Medical College, Vellore, India
,
Biju George
1   Departments of Hematology and Clinical Pathology*, Christian Medical College, Vellore, India
,
Vikram Mathews
1   Departments of Hematology and Clinical Pathology*, Christian Medical College, Vellore, India
,
Mammen Chandy
1   Departments of Hematology and Clinical Pathology*, Christian Medical College, Vellore, India
,
Alok Srivastava
1   Departments of Hematology and Clinical Pathology*, Christian Medical College, Vellore, India
› Author Affiliations

Financial support: This study was supported by a research grant from ‘Bayer hemophilia awards 2003’ and a grant – BT/PRO 948/Med/13/034/98 from the Department of Biotechnology, Ministry of Science and Technology, Government of India.
Further Information

Publication History

Received 14 September 2005

Accepted after revision 28 February 2005

Publication Date:
29 November 2017 (online)

Preview

Summary

Factor XIII deficiency is a rare autosomal (1:2,000,000) recessive disorder of blood coagulation usually attributed to mutations in the coagulation factor XIII (FXIII) A gene. We have studied the molecular basis of FXIII deficiency in eight unrelated South Indian patients. Their diagnosis was based on clinical history, normal plasma clotting times and increased solubility of fibrin clot in5 mol/l urea. Genomic DNA was screened for FXIII A gene defects by a novel PCR and CSGE strategy. Mutations were identified in all these patients. Five of these were novel mutations occurring in four patients. These included a novel c.210T>G transversion in homozygosity in exon 3 predicting a Tyr69X in the beta-sandwich domain in one patient. Another patient was compound heterozygote for a novel c.791C>T transition predicting a Ser263Phe in the core domain and a novel c.2045–1G>A transition at the acceptor splice junction of in tron 14. Two novel frame shifts were also identified in two patients in a homozygous condition. One of them resulted from a single base ‘G’ duplication (c.892_895dupG) at codons Ser290/Ala291fs affecting the core domain and the other was due to a single base ‘A’ duplication (c.1642_1644dupA) and at codonTyr547fs affecting barrel-1 domain. The remaining four patients had the previously reported Arg260His, Ser413Leu, and Val414Phe (n = 2) missense mutations in the core domain. The novel mutations identified were considered to be disease causative by studying the nature of mutation, the degree of conservation of the mutated aminoacid among transglutaminases of different species and by molecular modeling. Apart from describing a significant number of novel mutations, this report is the first study from Southern India to describe FXIII A gene mutations.